Physician profile
John Carroll
NPI 1992792881
$7,577.57
in general payments reported to CMS, 2019-2025
9 companies · $5,700 in 2025
The $5,700 reported for 2025 was more than what 97% of Geriatric Medicine (Family Medicine) providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $10.41 · 2022: $150 · 2024: $1,589 · 2025: $5,700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,220 · Food and Beverage: $69.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,220.00 |
| Food and Beverage | $69.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech, INC. | $6,080.00 | 2024-2025 | |
| F. Hoffmann-La Roche Ag | $1,140.00 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $150.00 | 2022 | |
| Mylan Specialty L.P. | $108.94 | 2019 | |
| Janssen Pharmaceuticals, INC | $29.89 | 2024 | Xarelto |
| Dexcom, INC. | $23.10 | 2024 | Dexcom G6 Transmitter |
| Abbvie INC. | $19.11 | 2019 | |
| Pfizer INC. | $16.12 | 2024 | |
| Fisher Scientific Company L.L.C. | $10.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Carroll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.